The Cumming School of Medicine (CSM) and Alberta Health Services (AHS) are pleased to announce a funding opportunity for University of Calgary (UC) investigators. This opportunity will support the Eyes High strategic vision of leadership in high-impact clinical research at UC and promote the objectives of AHS strategy for research innovation and analytics.
Key goals for this fund:
- To increase the number of high impact, UC-led clinical research studies
- To increase UC’s success in attracting Tri-Council funding for clinical studies
- To improve the Alberta health system and the health of Albertans
Funds will be available to support high-impact clinical studies that improve health or influence clinical practice and healthcare delivery. Seed funding and funds for planning and pilot work will also be available to support high-quality research that will be competitive for peer-reviewed funding and/or partnerships with industry.
Applications will be submitted to the Calgary Centre for Clinical Research (CCCR) through an online application form and adjudicated by a CSM review committee with input from external peer reviewers as required.
Applications for Seed Grants will be accepted twice annually (Deadlines: July 15 and December 15). Seed grants will be awarded up to $50,000. Proposals may include requests for up to $25,000 in cash; the remainder (i.e., up to the maximum of $50,000) may be used to pay for work done in a CSM clinical research facility (Clinical Research Unit [CRU] or Heritage Medical Research Clinic [HMRC]).
Applications for Pre-submission/Planning/Data Collection Grants can be submitted at any time during the year. Pre-submission/Planning/Data Collection grants will be awarded up to $10,000. Priority will be given to pre-submission applications that request a greater proportion of funds to be used to pay for work done in a CSM clinical research facility (Clinical Research Unit [CRU] or Heritage Medical Research Clinic [HMRC]) rather than cash.
Note: Pre-submission/Planning/Data Collection applications related to the upcoming CIHR Clinical Trials Fund program are currently accepted.
Please review the revised Terms of Reference and the FAQ prior to preparing your application.